April 2004
Volume 45, Issue 4
Free
Retinal Cell Biology  |   April 2004
Energy Substrate Requirements of Rat Retinal Pigmented Epithelial Cells in Culture: Relative Importance of Glucose, Amino Acids, and Monocarboxylates
Author Affiliations
  • John P. M. Wood
    From the Nuffield Laboratory of Ophthalmology, University of Oxford, Oxford, United Kingdom; and
  • Glyn Chidlow
    From the Nuffield Laboratory of Ophthalmology, University of Oxford, Oxford, United Kingdom; and
  • Mark Graham
    From the Nuffield Laboratory of Ophthalmology, University of Oxford, Oxford, United Kingdom; and
    AstraZeneca, Loughborough, United Kingdom.
  • Neville N. Osborne
    From the Nuffield Laboratory of Ophthalmology, University of Oxford, Oxford, United Kingdom; and
Investigative Ophthalmology & Visual Science April 2004, Vol.45, 1272-1280. doi:https://doi.org/10.1167/iovs.03-0693
  • Views
  • PDF
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      John P. M. Wood, Glyn Chidlow, Mark Graham, Neville N. Osborne; Energy Substrate Requirements of Rat Retinal Pigmented Epithelial Cells in Culture: Relative Importance of Glucose, Amino Acids, and Monocarboxylates. Invest. Ophthalmol. Vis. Sci. 2004;45(4):1272-1280. https://doi.org/10.1167/iovs.03-0693.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

purpose. To determine the metabolic conditions that provide maintenance of viability for cultured rat RPE cells and to determine whether monocarboxylates such as lactate or pyruvate, which are known to exist at high concentrations in the subretinal space, can provide an alternative energy source to maintain cells when other nutritive supplies are limited.

methods. Cultured rat RPE cells (passage 2–4), in the absence of serum, were subjected to different metabolic challenges relating to glucose, amino acid, or oxygen deprivation. Lactate or pyruvate was added to some cells in each instance to determine whether cells could be maintained by using these substances as fuel sources for metabolic reactions. Cell viability was assessed after treatments, and in some cases proliferation rates and appearance of apoptosis-like DNA cleavage were also investigated by terminal deoxynucleotidyl-transferase UTP-linked nick-end labeling (TUNEL). Western blot analysis was used to determine the expression of transporters for glucose and monocarboxylates in these cells.

results. RPE cell viability was partially reduced in the absence of glucose or with glycolytic inhibition. Lactate or pyruvate did not prevent these reductions. Inhibition of transaminase reactions with aminooxyacetic acid (AOAA) in the absence of glucose caused a complete loss of viability that was reversed by pyruvate or lactate. MCT inhibition was detrimental to RPE cell viability only at high concentrations (500 μM) in the presence of glucose but blocked the protective effect of pyruvate-lactate in the presence of AOAA at 1 μM.

conclusions. Rat RPE cells require glucose as their primary metabolic substrate in culture, but can metabolize glutamine in its absence. When glucose and glutamine are limiting, RPE cells can metabolize monocarboxylates such as lactate or pyruvate. These data provide evidence that such cells are able to withstand various types of insult brought about by nutrient deprivation, by altering their pathways of energy production.

The retinal pigmented epithelium (RPE) forms a monolayer of tightly linked cuboidal cells that juxtapose the posterior face of the retina. 1 2 3 The apical surface of the RPE is separated from the neural retina by the subretinal space, and it is across this space that these cells mediate the transport of metabolic intermediates, waste products, ions, and fluid components between the choriocapillaries and the retina and vice versa. For this purpose, the RPE expresses a variety of different transporter proteins on both its basal side, adjacent to Bruch’s membrane and the porous choriocapillaries, and on its apical surface, in close apposition to the retinal photoreceptors. 3 The combined movement of ions and fluid components between the retina and the RPE aids retinal attachment. 2 Because the RPE forms the outer blood–retinal barrier and is essential for removal of waste products and entry of nutrients into the retina, any disturbance in normal physiological functioning of these cells necessarily has detrimental consequences for the retina. It is well documented that defects in RPE functioning may underlie various sight-threatening conditions, such as diabetic retinopathy, age-related macular degeneration, and proliferative vitreoretinopathy. 3 4 5  
The retina is known to produce high quantities of the glycolytic end product, lactate. 6 7 Indeed, the concentration of lactate in the subretinal space is approximately 7 to 13 mM. 8 Studies performed with retinal preparations in vitro have shown that Müller cells convert a large fraction of the glucose they take up from the blood supply to lactate, rather than oxidizing it through the Krebs’ cycle. 7 9 10 Much evidence also exists to demonstrate that on release from the Müller cells, lactate is taken up by photoreceptors for use as a fuel in cellular energy production. 9 10 This knowledge is bolstered by the fact that neurotransmission in the inner retina is predominantly fueled by glycolysis, whereas oxidative metabolism provides energy for outer retinal processes such as phototransduction. 11 Indeed, lactate is the preferred Krebs’ cycle substrate for photoreceptors. 12 This is also the case for other neurons during the neonatal period or when glucose availability is low—for example, during episodes of hypoglycemia, ischemia, or starvation or in ketosis. 13 The phenomenon of glia-released lactate’s acting as a fuel for neuronal metabolism in the brain has been postulated and is termed the astrocyte–neuron lactate shuttle hypothesis (ANLSH). 14 15  
Measurements of lactate efflux into the vortex veins have indicated that most of this metabolite leaving the retina comes out through the RPE. 16 This process has been shown to be activity dependent and to increase during dark adaptation. 16 The facilitated transport of lactate and other monocarboxylates, including pyruvate, β-hydroxybutyrate, and acetoacetate, across the plasma membrane is mediated by a family of transporter proteins named the monocarboxylate transporters (MCTs). 13 These transporters are saturable and proton coupled; to date, 14 distinct family members have been described. 13 17 Movement of monocarboxylates by MCTs is stimulated solely by concentration gradients of both these compounds and by protons. No additional energy source appears to be required. Recent immunohistochemical studies have shown that MCTs are expressed by both retinal and RPE cells in vivo. 18 19 20 21 MCT1, -2, and -4 are present in the retina, 20 21 and MCT1 and -3 are expressed in RPE cells in vivo. 18 19 The expression pattern of MCTs in the RPE is striking, with MCT3 confined to the basolateral membrane and MCT1 expressed on the apical surface. 19 The presence of MCT4 has been demonstrated in very low amounts in the neonatal rat RPE by immunoblotting experiments, but the subcellular localization of this isoform remains unclear. 20 It has been hypothesized that MCT1 is responsible for removal of lactate from the subretinal space and that MCT3 subsequently shuttles this monocarboxylate into the choroidal blood supply. 19 20 Indeed, RPE preparations have been shown to transport lactate and protons. 22 23 Suggestions that lactate movement across the RPE is accompanied by water flux supports the notion that MCTs are important in helping to maintain retinal attachment. 
The exposure of the apical face of the RPE to high concentrations of lactate and the presence of MCTs on both surfaces of these cells indicate that this metabolite necessarily enters these cells. The question arises, therefore, as to whether lactate, under different circumstances, can be used as a substrate for energy production by the RPE. This question is due to the knowledge that lactate can be used by many cell types as a source of energy, particularly when glucose availability is low. The present series of investigations was performed therefore to determine what metabolic substrates are used by cultured rat RPE cells to maintain viability and also to determine specifically whether cultured RPE cells can preserve viability by metabolizing monocarboxylates such as lactate when added to the bathing medium, either under control conditions or when deprived of essential nutrients. Data obtained from these investigations should provide an insight into the susceptibility of RPE cells to nutrient deprivation and will provide information that may enable these cells and hence the neuroretina, to be protected from such insults, in vivo. 
Materials and Methods
Culture of Rat Retinal Pigmented Epithelial Cells
Fetal bovine serum (FBS; European Community [EC] approved), Ham’s F-10 medium, glucose-pyruvate-lactate–free Dulbecco’s modified Eagle’s medium (DMEM), amphotericin B, sodium pyruvate, and trypsin (0.25% wt/vol) were from Invitrogen (Paisley, UK), and tissue culture flasks and 24-well plates were from Fahrenheit Laboratory Supplies (Northampton, UK). Polyclonal antiserum raised against MCT1 and the monoclonal anti-actin were obtained from Chemicon (Chandler’s Ford, UK). Polyclonal anti-glucose transporter 1 (GLUT1) was obtained from Insight Biotechnology (Wembley, UK). All culture plastic ware was obtained from Sarstedt (Leicester, UK), and all other chemicals from Sigma-Aldrich (Poole, UK). 
The culture method for rat RPE cells was modified from that of Edwards. 24 Litters of 8 to 10 rats were used for the production of each culture. Enucleated eyes from 8- to 12-day-old rat pups were incubated overnight in the dark at room temperature in 10 mL balanced salt solution (BSS; 136.9 mM NaCl, 5.4 mM KCl, 4.2 mM NaHCO3, 0.34 mM NaH2PO4, 0.44 mM KH2PO4, 5.55 mM glucose, and 100 μg/mL gentamicin; pH 8.0) containing 0.3 mM CaCl2. After incubation, BSS was removed and replaced with calcium-free BSS containing 0.1 mM EDTA, 1 mg/mL trypsin, and 70 U/mL collagenase (pH 8.0), and the eyes were incubated in a shaking water bath at 37°C for 45 minutes. 
Enzyme reactions were stopped by transferring eyes to sterile 35-mm diameter culture dishes containing 3 to 5 mL nutrient mixture F-10 (Ham’s F-10 supplemented with glucose at a final concentration of 25 mM, 2.5 mg/mL amphotericin B, 100 μg/mL gentamicin, and 10% FBS). The anterior portion of each eye was removed just below the ora serrata before careful removal of the retina with sterile forceps. The resultant eyecups were washed in culture medium and the RPE removed by gentle scraping with a flame-tipped Pasteur pipette into 3 to 5 mL fresh culture medium. The RPE suspension was centrifuged (80g for 8 minutes at 4°C), and the pellet was resuspended in enzyme- and calcium-free BSS for washing. After centrifuging again, the cells were resuspended in calcium-free BSS with 1 mg/mL trypsin and incubated at 37°C for 5 minutes. The reaction was stopped by the addition of culture medium, before recentrifuging the cells and resuspending them in 5 mL fresh medium. After a brief, gentle trituration, the cells were transferred to a sterile 25-cm2 culture flask and grown in an incubator in saturating humidity and 5% CO2 at 37°C. 
Cells were confluent within 7 days, and passaging was performed at the ratio of 1 to 3. Rat RPE cells were used for experimentation between passages 2 to 4, in 96-well plates (viability assays), 24-well plates (proliferation assays), or on glass coverslips previously coated with poly-l-lysine (10 μg/mL, 20 minutes; DNA breakdown detection). Positive labeling by immunocytochemistry with the anti-cytokeratin KG 8.13 anti-serum (Sigma-Aldrich) confirmed the identity and homogeneity of the cultured cells (Fig. 1)
Treatment of Cells
The medium used for investigating the metabolic substrates required for maintenance of rat RPE cells in culture was glucose- and lactate-pyruvate–free DMEM. In all experiments, comparisons between FBS-containing and -free media were initially undertaken to determine the involvement of this nutrient additive in any system. Generally, though, FBS was left out of the medium in experimental situations because of its unknown constitution (e.g., unknown glucose and monocarboxylate concentrations). For glucose-dependence experiments, some cultures were incubated in glucose-free culture medium, some were treated with the glucose transport (GLUT1) inhibitor cytochalasin B (CCB), and some were treated with the glycolytic inhibitor, iodoacetic acid (IOA). To determine the importance of monocarboxylates, pyruvate or lactate was added or omitted in some cases and an inhibitor of monocarboxylate transport, α-cyano-4-hydroxycinnamate (4-CIN), was also used. Aminooxyacetic acid (AOAA) was used to inhibit transaminase reactions. Concentrations used for all compounds were as previously reported for the respective inhibitory activities. 13 25 26 27 In some instances cultures were subjected to various periods of anoxia to inhibit aerobic metabolism, by placing them in a humid chamber at 37°C perfused with 95% N2-5% CO2 for 4 hours before sealing them for the appropriate amount of time, as reported previously. 28  
Proliferation of RPE Cells
Cells used for proliferation studies were assessed to be approximately 70% confluent before treatment began, as described earlier. Six hours before the end of the appropriate treatment regimen, [3H]-thymidine was added (1 μCi/mL). At the end of the incubation, cells were washed twice with phosphate-buffered saline (PBS; 137 mM NaCl, 5.4 mM KCl, 1.28 mM NaH2PO4, 7 mM Na2HPO4; pH 7.4) and lysed with ice-cold 0.1 M NaOH. The amount of incorporated [3H]-thymidine was determined with liquid scintillation spectroscopy. Samples were taken from each well before counting radioactivity for protein determination, 29 to equalize the radiolabel in each case. 
Cell Viability Studies
The assay used to assess cell viability as a measure of the potential for metabolic substrates to maintain RPE cells in culture was the 3(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction assay, modified from the method of Mosmann. 30 This assay has been widely used in recent years to provide a quantitative assessment of cellular viability. It is generally accepted that MTT is reduced to form an insoluble, blue formazan product by accepting electrons from cellular reducing equivalents such as nicotinamide adenine dinucleotide phosphate (NADH), reduced nicotinamide adenine dinucleotide phosphate (NADPH), or succinate. 26 31 It thus acts as a measure for both cytoplasmic and mitochondrial metabolic activity and hence is a useful means to determine whether metabolic substrates are used to provide respiratory energy. Studies in which MTT reduction in cells was assessed by microscope have determined that a percentage decrease in MTT reduction for a given group of cells tends to reflect a decrease in the ability of all cells present to reduce the dye (Wood JPM, unpublished observation, 2001). It does not reflect the complete loss of MTT-reducing capability in some cells, whereas others remain at control levels. 
Briefly, cells were subjected to the appropriate treatments for the required times and then MTT was added to wells at a final concentration of 0.5 mg/mL for 1 hour further at 37°C. After this time, medium was removed from the cultures and reduced MTT (blue formazan product) was solubilized by adding 100 μL of dimethyl sulfoxide (DMSO) to each well. After plates were agitated for 15 minutes, the optical density of the solubilized formazan product in each well was measured using an automatic microplate reader (Titertek Plus MS212; ICN Flow, Thame, UK) with a 570-nm test wavelength and a 690-nm reference wavelength. 
Assessment of DNA Breakdown with the TUNEL Procedure
For the terminal deoxynucleotidyl-transferase UTP-linked nick-end labeling (TUNEL) procedure, treated cells on coverslips were fixed in 4% paraformaldehyde for 20 minutes and then immersed in PBS containing 0.1% Triton X-100 (PBS-T). The labeling procedure was performed exactly as described previously. 28 The labeled RPE cells on coverslips were washed in PBS, mounted on glass slides, and visualized with Nomarski optics. Some cells were treated after fixation but before TUNEL staining with DNase I (0.1 mg/mL) for 15 minutes at 37°C as a positive control. 
Assessment of Transporter Expression in Cultured Rat RPE Cells by Immunoblot Analysis
Rat RPE cells (passage 3) were grown to confluence (approximately 2 × 106 cells), washed and harvested in PBS (35.5°C), and collected by centrifugation (80g for 8 minutes at 4°C). Cells were sonicated in buffer (20 mM Tris-HCl [pH 7.4], containing 2 mM EDTA, 0.5 mM EGTA, 1 mM dithiothreitol, 50 μg/mL leupeptin, 50 μg/mL pepstatin A, 50 μg/mL aprotinin and 0.1 mM phenylmethylsulfonyl fluoride). An equal volume of sample buffer (62.5 mM Tris-HCl [pH 7.4], containing 4% SDS, 10% glycerol, 10% β-mercaptoethanol, and 0.002% bromophenol blue) was added, and samples were incubated on ice for 30 minutes followed by 30 minutes of vigorous shaking. Electrophoresis of samples was performed as reported previously, 28 using 10% polyacrylamide gels containing 0.1% SDS. Proteins were transferred to nitrocellulose and blots were stained as previously described 28 for the presence of MCT1 and GLUT1, to demonstrate that the cells were able to take up monocarboxylates and glucose, respectively. The presence of actin was assessed in cell extracts as a positive control. 
Immunocytochemistry
RPE cells grown to confluence on borosilicate glass coverslips were fixed in 4% paraformaldehyde for 10 minutes and then immersed in PBS-T. Labeling for the presence of MCT1 was achieved by incubating fixed cells overnight at 4°C with a chicken anti-rat MCT1 antibody (diluted 1:500 in PBS-T). After incubation with the primary antiserum, coverslips were washed in PBS-T and then incubated in PBS-T containing chicken antibody conjugated to biotin (Vector Laboratories, Peterborough, UK; 1:100) and horse serum (1:100) for 30 minutes. Subsequent to a further wash with PBS-T, immunoreactivity was visualized with a standard avidin-peroxidase detection kit (Vector Laboratories) with 0.1% (vol/vol) H2O2 and 0.1% (wt/vol) 3′-,3′-diaminobenzidine in PBS-T. After labeling, coverslips were mounted in PBS containing 1% glycerol and visualized by light microscopy. 
Statistics
All experiments were performed with control samples in the same plates. Data were thus analyzed for significance using the Student’s paired t-test. In the main, data are expressed as the mean percentage of control value ± SEM. 
Results
Rat RPE cells in culture formed a homogeneous population and were clearly labeled for RPE-specific cytokeratins at passage 3 (Fig. 1)
Glucose Deprivation Studies
Cultured rat RPE cells that were subjected to glucose deprivation exhibited a significantly reduced viability (68.9% ± 6.8% of the untreated control value) after 24 hours (Fig. 2A) . This loss of MTT-reducing potential was not exacerbated up to 120 hours after glucose removal. There was no significant difference in the viability of cells incubated in medium containing 5 or 25 mM glucose up to 120 hours. The presence of 5 mM of either pyruvate or lactate in the medium did not prevent the reduction in viability of cells caused by glucose withdrawal (Fig. 2B)
The critical nature of altering glucose reserves in the medium is illustrated in Figure 3 . After glucose depravation for up to 24 hours, there was a small decrease in the viability of cells (approximately 30%; Figs. 2 3 ). Reintroduction of 25 mM glucose to the medium after 24 hours of its deprivation initiated a process leading to death of the RPE cells (Fig. 3) . By 72 hours after reintroduction of glucose to cells that had been deprived of the sugar for 24 hours, only 10.3% ± 2.3% of the control level of MTT-reducing potential could be detected in cultures (Fig. 3A) . This process was characteristic of apoptosis, as defined by positive nuclear labeling by the TUNEL reaction (Fig. 3C)
Transport Inhibition
The glycolytic inhibitor IOA caused a dose-dependent reduction in viability of rat RPE cells over 24 hours, which was at its maximum at 6 μM (Fig. 4) . The addition of monocarboxylates did not prevent the decreased viability. The glucose transport inhibitor CCB, in the presence of glucose, also caused a dose-dependent decrease in cell viability after 24 hours or more (Table 1) . The MCT inhibitor 4-CIN had no effect on RPE cell viability at low concentrations but became slightly and significantly toxic when increased to 500 μM for 72 hours (Table 1)
Contribution of Hexose Monophosphate Shunt
Figure 5 illustrates the role of hexose monophosphate shunt reactions in maintaining RPE cell viability over 24 hours. The reduction in viability caused by blocking glycolysis in the presence of glucose with 10 μM IOA was not significantly enhanced by anoxia, which itself had no significant influence on viability after 24 hours. There was, however, an additive detrimental effect when combining anoxia for 24 hours with a medium containing no glucose. In such cultures, cell viability was almost completely lost. These data suggest that glucose removal has a greater detrimental effect than glycolytic blockade, which may indicate that this sugar is involved in additional cellular reactions. 
Transaminase Inhibition
The pantransaminase inhibitor AOAA had no effect in the presence of glucose, but in the absence of the sugar, it dose dependently reduced cell viability to approximately 20% of the control after 72 hours (Fig. 6A ; Table 2 ). In contrast to the effects of glucose deprivation and IOA, the effect of AOAA was significantly counteracted by the presence 5 mM of either lactate or pyruvate in the incubation medium (Fig. 6B) . This protective effect of monocarboxylates was prevented by co-incubation with the MCT inhibitor 4-CIN or by concomitant experimental anoxia (Table 3) . Conducting incubations in glucose-glutamine–free medium (Table 2) led to a similar reduction in RPE cell viability in response to AOAA, whereas l-cycloserine (l-CS), a specific alanine aminotransferase inhibitor, had no effect on cell viability (Table 2) . When glucose was present, incubating cells in glutamine-free medium had no significant effect on cell viability (Table 2)
Proliferation Studies
Incubation of nonconfluent cells in medium without serum, glucose, and monocarboxylates for 24 hours led to an incorporation of 0.52 picomoles [3H]thymidine per well. When glucose was present in the medium, it stimulated proliferation of cells, as measured by [3H]thymidine uptake, by 197.4% ± 11.6% (5 mM) and 205.9% ± 16.6% (25 mM) of the level of cells treated with glucose-free medium. Lactate (5 mM; 120.3% ± 16.3%) or pyruvate (96.9% ± 5.5%) had no significant effect on cell proliferation (Table 4)
Transporter Expression in Cultured Rat RPE Cells
Analyses of two distinct rat RPE cell lines by electrophoresis and Western blot analysis showed that MCT1 and GLUT1 were expressed, indicating that the cells had the potential for taking up monocarboxylates and glucose from the medium, respectively. Immunoblots probed for the presence of actin revealed that protein levels were similar in each sample (Fig. 7) . Immunocytochemical studies revealed that cells were labeled in a homogeneous manner for MCT1 immunoreactivity (Fig. 7B) . A micrograph shown is representative of cells from four different cultures labeled for MCT1. 
Discussion
In this study, rat RPE cells in culture (passages 2–4) clearly used glucose as the primary energy source. However, metabolism of amino acids such as glutamine by these cells provided an alternative means of retaining viability. Furthermore, the monocarboxylates, pyruvate, or lactate were used as substrates, but only when glucose availability was low, and amino acid metabolism was inhibited. RPE cells, in vivo, are thought to use both oxidative and nonoxidative pathways of glucose catabolism, 3 32 33 34 although bovine RPE cells have been demonstrated to have a level of aerobic respiration that is only approximately half that of the retina. 25 These data provide evidence that rat RPE cells can overcome deprivation of preferred energy substrates by switching modes of metabolic energy production, which suggests that such cells may be able to resist insults in vivo, such as hypoxia or hypoglycemia, by implementing alternative pathways of metabolism. 
It is well known that some cell types reduce their rate of oxidative metabolism and convert to high rates of glycolysis in culture. 35 36 In such cells, glucose is either metabolized through glycolysis to form pyruvate or through the hexose monophosphate shunt (pentose phosphate pathway) to produce pentose sugars necessary for nucleotide synthesis. Pyruvate then preferentially undergoes anaerobic fermentation to lactate, rather than being used as a substrate for oxidative metabolism. Because the amount of pyruvate passing into the Krebs’ cycle is low, the anaerobic lactate production constitutes a significant energy source. This is despite the fact that the energy yield from anaerobic lactate synthesis (2 moles adenosine triphosphate [ATP] per mole of glucose) is much less than that produced by oxidative metabolism (approximately 36 moles ATP per mole of glucose). The reasons that some cultured cells predominantly rely on nonoxidative pathways for glucose catabolism remains unclear. It has been suggested that prolonged culturing leads to an uncoupling of enzyme activities connecting glycolysis with the Krebs’ cycle, such as pyruvate dehydrogenase, phosphoenolpyruvate carboxykinase, or pyruvate carboxylase. 35 36 It is also possible that oxygen availability is much reduced because diffusion to cells through the culture medium is uncontrolled and may therefore be extremely limited. In the case of the rat RPE cells examined in the present study, reliance on oxidative pathways of metabolism was essentially lost, as shown by the fact that an incubation for 24 hours in an anoxic environment (Fig. 6) had no significant effect on cell viability. Previous reports have shown that prolonged exposure to anoxia, particularly in the case of human RPE cells, leads to apoptotic cell death, 28 37 38 but this effect was probably manifest through free radical intermediates, because it was blocked by flupirtine 37 and melatonin, 38 both of which possess free-radical–scavenging properties. 
A phenomenon that has been widely described is the Pasteur effect. This is the compensatory increase in anaerobic glycolysis implemented in response to an inhibition of mitochondrial oxidative respiration. An elegant study by Winkler et al. 39 has shown that both cultured rat retinal Müller cells (cell line RMC-1) and (human) RPE cells raise their rates of glycolysis in response to inhibition of mitochondrial respiratory processes by the Pasteur effect. Furthermore, inhibition of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) with 5 μM IOA in both cell types causes a decrease in the level of anaerobic but not aerobic ATP production with a resultant loss of cellular viability. 39 These data show that, although such cells have the ability to withstand metabolic challenges resulting from a decrease in the oxygen supply (i.e., hypoxia, ischemia), they are ultimately dependent on an adequate supply of glucose for metabolic energy production. This is in agreement with the present data that showed glucose to be the preferred substrate for RPE cell metabolism. 
In the present study, the viability of rat RPE cells began to show a reduction after 6 hours of glucose deprivation, although this effect was only statistically significant at 24 hours. Cultured human Müller cells have been shown to maintain their aerobic ATP levels for 4 hours in the absence of glucose, but under anaerobic conditions or when challenged with IOA, ATP levels were diminished within this time. 7 Moreover, these cells were completely resistant to experimental anoxia; and, furthermore, approximately 99% of the glucose used by these cells was metabolized to lactate under control conditions. These data imply that Müller cells in situ predominantly metabolize glucose, sparing oxygen for inner retinal neurons. This would probably be the case for the glycolytically active RPE cells, which could spare oxygen for photoreceptor metabolism. As Winkler stated, “Retinal Müller cells in culture are resistant to anoxia or absence of glucose, which provides a basis for understanding why Müller cells are less susceptible than neurons to ischemia or hypoglycemia.” 7 The same reasoning holds for cultured RPE cells, which although susceptible to anoxia, maintain their viability for more than 24 hours in the absence of oxygen. Photoreceptors are also able to partially upregulate glycolysis in response to mitochondrial inhibition by the Pasteur effect, 40 but, unlike RPE and Müller cells, these cells require glycolysis and oxidative respiration for energy production, because blockade of both processes together leads to a loss of receptor potential and a depletion of intracellular ATP. This would dictate that photoreceptors, although resistant to short episodes of mitochondrial inhibition, are also affected by a limited glucose supply. Moreover, reports have stated that photoreceptor metabolism can be maintained by utilization of lactate, previously released by Müller cells, as the end product of glycolysis. 9 10 This has been questioned recently, however, by a study showing that retinal neurons and photoreceptors preferentially metabolize glucose, as long as the ambient supply of this sugar is adequate. 41  
When rat RPE cells were deprived of glucose for 24 hours, cultures decreased to approximately 70% of their control viability levels. This effect was not further enhanced up to 120 hours of glucose deprivation, suggesting that alternative means of producing energy may have been implemented by glutaminolysis, in the absence of this sugar. Glucose was obviously the primary substrate for energy production in these cells, as complete viability was retained in the absence of glutamine, as long as glucose was present. Glucose is transported across cell membranes by specific, facilitated glucose transporters (GLUTs). 42 43 The predominant transporter present in the RPE, on both the apical and the basolateral surface is GLUT1, 44 as was shown to be expressed in these cells in the current study, although both GLUT1 and GLUT3 are expressed within the neuroretina. 45 Comparison between two different glucose concentrations in the present study (5 and 25 mM) showed that both were equally effective in maintaining cells up to 120 hours. The lower of the two concentrations was evidently present in sufficient quantities to prevent loss of cellular viability. The cellular proliferation studies confirm these findings, as both 5 and 25 mM glucose stimulated an increase in incorporation of [3H]thymidine above control glucose-free levels. Neither pyruvate nor lactate had a significant effect on proliferation in the absence of glucose. 
Blocking glycolysis with the GAPDH inhibitor IOA and inhibiting glucose entry with CCB both led to much more pronounced reductions in viability than glucose deprivation itself. This may reflect the broad specificity of the two compounds. CCB, for example, is known to act as an inhibitor of microtubule formation as well as a glucose transport inhibitor. 25 It is also pertinent to note that IOA can inhibit malate dehydrogenase, 46 which would consequently inhibit oxidative reactions fueled by glutamine. In the case of IOA, any remaining MTT-reducing activity would therefore have to be generated by nonoxidative and nonglycolytic pathways. Indeed, by comparing treatments of RPE cells with IOA-anoxia against glucose-deprivation anoxia, it can be determined that approximately 20% of the glucose takes part in a pathway that is not blocked by IOA (Fig. 5) . In fact, this is likely to be the hexose monophosphate shunt pathway, which has been reported to be active in cultured human RPE cells (21% ± 2% of the glucose used 47 ) and also in cultured chick RPE. 48 The hexose monophosphate shunt pathway, which is active in the retina in normal (nondiabetic) rats, 49 serves as an important alternative catabolic pathway for glucose that additionally provides for production and disposal of pentose sugars used—for example, in nucleic acid biosynthesis—and for the generation of NADPH. Because NADPH is another cellular reducing equivalent used in MTT reduction, this assay should remain responsive even during inhibition of GAPDH with IOA, the point at which hexose monophosphate shunt products can be filtered back into conventional glycolysis. A previous study using cultured human RPE cells indicated that 10 μM IOA leads to an incomplete inhibition of GAPDH activity. 39 It is therefore possible that with the use of this concentration of IOA, some glucose was still metabolized glycolytically, as reflected in the 20% mentioned earlier and defined to be due to the hexose monophosphate shunt pathway. This is unlikely, however, because this concentration of IOA was shown to inhibit GAPDH by approximately 97% in human RPE cells and would be unable by itself to maintain some 20% of normal glucose metabolism by glycolysis. 
Reintroduction of glucose to rat RPE cells that had been deprived of this sugar for 24 hours resulted in a slowly developing cellular death process that was characteristic of apoptosis, as previously demonstrated after anoxia, 37 protein kinase C inhibition, 28 and glutathione biosynthesis inhibition. 50 This probably reflects the influence of either osmotic shock, which would destroy cells rapidly, or sudden hyperglycemic trauma to the cells. In brain neurons, hyperglycemia has been shown to result in a build-up of acidosis and a depletion of cellular NADH. 51 These processes would facilitate free radical formation, activation of pH-dependent endonucleases and an alteration of intracellular calcium regulation with resultant mitochondrial failure. All these processes, once activated, would lead to apoptosis-like death of cells. 52 In support of this claim, cultured human RPE cells have been shown to downregulate levels of Na+/H+-anti-port activity after long-term exposure to 26 mM glucose. 53 This is known to lead to widespread ionic gradient alterations in cells and possibly to apoptotic death. 54  
To help to generate sufficient energy, many cultured cells take up glutamine in quantities that far exceed the requirement for protein synthesis. 36 The extra glutamine is deaminated and shuttled into the Krebs’ cycle to form a significant energy source in the process of glutaminolysis. The primary method of cell growth is therefore a combination of the synthesis of biomass from the energetic intermediates pyruvate and lactate and from ribose sugars derived from hexose monophosphate shunt reactions. In the present study, glucose appeared to be the primary substrate for energy production in cultured rat RPE cells, but glutaminolysis reactions occurred when this sugar was absent, as reported previously for cultured chick RPE cells. 33 This was illustrated by the effect of the transaminase inhibitor AOAA in the absence of glucose, compared with its lack of influence on cell viability in the presence of the sugar. AOAA is a general inhibitor of transaminase reactions 27 and therefore blocks all amino acid-derived reactions that contribute to maintenance of cell viability. To determine which amino acid was mainly involved in cellular metabolic reactions, a specific transaminase inhibitor was also tested (l-CS, an alanine amino-transferase inhibitor 27 ) and had no effect. Furthermore, performing incubations in a medium without glutamine and glucose had an effect similar to that of AOAA, suggesting that glutamine was the essential component used by RPE cells. The data also indicate that the monocarboxylates pyruvate and lactate can be used by these cells, but only as an alternative to glutamine, as substrates for the Krebs’ cycle. This was confirmed by the finding that the protective action of pyruvate or lactate in such situations was counteracted by concurrent anoxia, which would prevent oxidative pathways of metabolism. In agreement with the present data, cultured Müller cells incubated with IOA could not maintain their ATP levels, even in the presence of lactate, pyruvate, glutamate or glutamine providing further evidence that oxidative metabolism plays only a minor role in these cells. 7 In the present study, however, it was clearly demonstrated that oxidative pathways of metabolism function in rat RPE cells in the absence of glucose. This is evidenced by the role that glutamine or, in its absence, the monocarboxylates pyruvate or lactate play in maintaining cell viability. It appears, then, that RPE cells are not as completely reliant on glycolytic pathways of energy production as are Müller cells. 
That pyruvate and lactate can aid maintenance of viability of RPE cells, even if only in the absence of glucose and amino acid metabolism, demonstrates that these compounds enter the cells. It is well known that monocarboxylates pass through plasma membranes by specific transporters, the MCTs. 13 17 RPE cells express a complement of MCTs (mainly MCT1 and -3, but can express trace amounts of MCT4), which are retained in culture. 18 19 20 To demonstrate that rat RPE cells at passage 3 express transporters capable of taking up monocarboxylates, it was shown in the present study that MCT1 is expressed by these cells. Because it is thought that these cells organize themselves in culture with their apical surfaces pointing upward, 55 it would seem reasonable to assume that the MCT isoform responsible for monocarboxylate entry in this case is MCT1, which is expressed on the apical face in vivo. 19 The specific uptake of pyruvate or lactate by MCTs is further suggested by the blockade of the effects of these compounds by 4-CIN, a known MCT inhibitor. 13 56 That lactate acts in a similar way to pyruvate indicates that cultured rat RPE cells also express one or more lactate dehydrogenase isoenzymes, as shown previously. 32  
As previously discussed, cultured RPE cells may be expected to have an increased rate of glycolysis compared with cells in vivo. These cells therefore may be expected to express a distinct complement of transporters to clear the additional lactate. A recent report 57 has demonstrated that cells (Xenopus laevis oocytes) that are highly glycolytic preferentially express the MCT4 isoform and, indeed, the transformed human RPE cell line ARPE-19 expresses MCT4 in large amounts, 58 as distinct from RPE cells in vivo. Furthermore, in the present investigation, low concentrations of 4-CIN blocked lactate-pyruvate entry into cells, but were not toxic themselves. The higher concentration of 4-CIN (500 μM) was toxic to rat RPE cells after 72 hours. The results obtained with this MCT inhibitor may also be explained by differential expression of MCT isoforms with respect to cells in vivo. For example, MCT4, which is expressed at only trace levels by rat RPE cells, in situ, is blocked by a much higher concentration of 4-CIN than MCT1 (K 0.5 is reported to be 991 ± 148 μM for MCT4 compared with 166 μM for MCT1 in transfected oocytes 59 ). This would be consistent with these cells expressing MCT4 to export lactate and blockade with the high concentration of 4-CIN leading to intracellular acidosis and gradual cell death. It is suggested, however, that rat RPE cells exposed to long-term culture may alter expression of their MCT complement to compensate for the altered metabolism shown in such cells. Determination of the expression of all MCTs in the RPE cells used in the present study may clarify the roles that these transporters play in monocarboxylate flux in such cells. 
Conclusions
In summary, rat RPE cells in culture have been shown to rely primarily on glucose and secondarily on glutamine to provide metabolic substrates to maintain viability. In the absence of both glucose and glutamine, the cells can use the monocarboxylates, pyruvate, or lactate to this end. An important conclusion to be drawn from this study is that under physiological conditions in vivo, monocarboxylates are probably not used by RPE cells. The polarized localization of MCT1 and -3 on opposing faces of these cells is likely, therefore, to be solely for the purpose of shuttling these compounds from the retina into the choroidal circulation. Bearing all these points in mind, however, these data indicate that RPE cells have the requisite machinery to metabolize monocarboxylates and are able to alter their substrates for energy production according to local substrate availability. This means that they have the capability to withstand both hypoxic and hypoglycemic insults. Furthermore, the data obtained in the present study lend support to the idea that, although useful, such culture preparations are not necessarily reflective of RPE cell function in vivo. 
 
Figure 1.
 
Rat RPE cells in culture. (A) Cells at passage 3, as commonly used for the experiments outlined. The micrograph shows that cells lost their pigmentation, but retained a homogeneous appearance. (B) Cells labeled with anti-cytokeratin KG 8.13 antibody, which is specific for RPE cells.
Figure 1.
 
Rat RPE cells in culture. (A) Cells at passage 3, as commonly used for the experiments outlined. The micrograph shows that cells lost their pigmentation, but retained a homogeneous appearance. (B) Cells labeled with anti-cytokeratin KG 8.13 antibody, which is specific for RPE cells.
Figure 2.
 
The effect of glucose deprivation on rat RPE cells in culture. (A) Treatment of cells with various media over a 120-hour period, showing the reduction in viability to approximately 70% of the untreated value when glucose was absent. In comparison, there was no significant difference between cells incubated in either 5 or 25 mM glucose. (B) The reduction of viability after 24 hours’ incubation in medium without glucose was not counteracted by 5 mM pyruvate or 5 mM lactate. *P < 0.05 compared with appropriate control cells untreated for the same period (i.e., medium not changed for the experiment although still containing 25 mM glucose by paired Student’s t-test analysis; n = 12).
Figure 2.
 
The effect of glucose deprivation on rat RPE cells in culture. (A) Treatment of cells with various media over a 120-hour period, showing the reduction in viability to approximately 70% of the untreated value when glucose was absent. In comparison, there was no significant difference between cells incubated in either 5 or 25 mM glucose. (B) The reduction of viability after 24 hours’ incubation in medium without glucose was not counteracted by 5 mM pyruvate or 5 mM lactate. *P < 0.05 compared with appropriate control cells untreated for the same period (i.e., medium not changed for the experiment although still containing 25 mM glucose by paired Student’s t-test analysis; n = 12).
Figure 3.
 
The effect of a reintroduction of 25 mM glucose to cells that had been deprived of the sugar for 24 hours. After incubation for 24 hours in standard culture medium without glucose, there was a reduction in cell viability (also shown in Fig. 2 ) to approximately 70% of the untreated cells’ viability (A). However, reintroduction of 25 mM glucose to cells after this 24-hour sugar deprivation promoted the induction of RPE cell death, which was noticeable after a further 48 hours in a glucose-containing medium. Photographs of cells labeled by the TUNEL reaction indicate that cells die by a process characteristic of apoptosis (C; 72 hours after reintroduction of glucose) that is not detected in cells that have not been subjected to prior glucose deprivation (B).
Figure 3.
 
The effect of a reintroduction of 25 mM glucose to cells that had been deprived of the sugar for 24 hours. After incubation for 24 hours in standard culture medium without glucose, there was a reduction in cell viability (also shown in Fig. 2 ) to approximately 70% of the untreated cells’ viability (A). However, reintroduction of 25 mM glucose to cells after this 24-hour sugar deprivation promoted the induction of RPE cell death, which was noticeable after a further 48 hours in a glucose-containing medium. Photographs of cells labeled by the TUNEL reaction indicate that cells die by a process characteristic of apoptosis (C; 72 hours after reintroduction of glucose) that is not detected in cells that have not been subjected to prior glucose deprivation (B).
Figure 4.
 
Dose-dependent effect of the glycolytic inhibitor, iodoacetic acid (IOA), on reduction of rat RPE cell viability after 24 hours, in medium containing glucose. IOA had a similar detrimental effect in such medium whether 5 mM pyruvate, 5 mM lactate, or no monocarboxylates were present. The effect of IOA (5 μM) was slightly but significantly less destructive when pyruvate was present. *P < 0.05 compared with appropriate control cells in medium without IOA, by paired Student’s t-test analysis (n = 9).
Figure 4.
 
Dose-dependent effect of the glycolytic inhibitor, iodoacetic acid (IOA), on reduction of rat RPE cell viability after 24 hours, in medium containing glucose. IOA had a similar detrimental effect in such medium whether 5 mM pyruvate, 5 mM lactate, or no monocarboxylates were present. The effect of IOA (5 μM) was slightly but significantly less destructive when pyruvate was present. *P < 0.05 compared with appropriate control cells in medium without IOA, by paired Student’s t-test analysis (n = 9).
Table 1.
 
Effect of Transport Inhibitors on Viability of Cultured Rat RPE Cells
Table 1.
 
Effect of Transport Inhibitors on Viability of Cultured Rat RPE Cells
Treatment (μM) Viability at 24 h Viability at 72 h
CCB (50) 54.1 ± 6.7* 27.1 ± 5.3, **
CCB (1) 93.4 ± 3.2 53.2 ± 6.5*
4-CIN (500) 97.3 ± 3.4 76.1 ± 7.6*
4-CIN (50) 101.3 ± 2.8 98.1 ± 3.2
4-CIN (1) 99.3 ± 4.6 99.2 ± 2.4
Figure 5.
 
Involvement of the hexose-monophosphate shunt for generation of a small proportion of cell energy in rat RPE cultures. Oxygen deprivation for 24 hours had no significant effect on cell viability, unlike IOA (10 μM) which reduced cells to approximately 25% of control metabolic activity. Although the effect of IOA was reduced slightly by concurrent anoxia, there was no detectable metabolic activity at all in cells incubated in a medium without glucose subjected to anoxia for 24 hours. *P < 0.05, when cells subjected to glucose and oxygen deprivation are compared with cells treated with IOA and anoxia, by paired Student’s t-test analysis (n = 8).
Figure 5.
 
Involvement of the hexose-monophosphate shunt for generation of a small proportion of cell energy in rat RPE cultures. Oxygen deprivation for 24 hours had no significant effect on cell viability, unlike IOA (10 μM) which reduced cells to approximately 25% of control metabolic activity. Although the effect of IOA was reduced slightly by concurrent anoxia, there was no detectable metabolic activity at all in cells incubated in a medium without glucose subjected to anoxia for 24 hours. *P < 0.05, when cells subjected to glucose and oxygen deprivation are compared with cells treated with IOA and anoxia, by paired Student’s t-test analysis (n = 8).
Figure 6.
 
The effect of the pantransaminase inhibitor AOAA on rat RPE cell viability in culture after 72 hours. (A) When AOAA was applied in the presence of glucose, there was no significant effect. There was a dose-dependent reduction in cell viability, however, when AOAA was present in medium without glucose, with the maximum reduction (to approximately 27% of the value of cells in the presence of glucose without AOAA) observed at 1 mM. *P < 0.05, **P < 0.01, compared with appropriate control cells in medium with glucose but without AOAA, by paired Student’s t-test analysis (n = 8). (B) The reduction in viability caused by 1 mM AOAA was significantly counteracted by 5 mM pyruvate or 5 mM lactate. *P < 0.05, compared with cells treated with AOAA alone by paired Student’s t-test analysis (n = 8).
Figure 6.
 
The effect of the pantransaminase inhibitor AOAA on rat RPE cell viability in culture after 72 hours. (A) When AOAA was applied in the presence of glucose, there was no significant effect. There was a dose-dependent reduction in cell viability, however, when AOAA was present in medium without glucose, with the maximum reduction (to approximately 27% of the value of cells in the presence of glucose without AOAA) observed at 1 mM. *P < 0.05, **P < 0.01, compared with appropriate control cells in medium with glucose but without AOAA, by paired Student’s t-test analysis (n = 8). (B) The reduction in viability caused by 1 mM AOAA was significantly counteracted by 5 mM pyruvate or 5 mM lactate. *P < 0.05, compared with cells treated with AOAA alone by paired Student’s t-test analysis (n = 8).
Table 2.
 
Influence of Transaminase Inhibitors on Viability of Cultured Rat RPE Cells in Glucose-Free Medium
Table 2.
 
Influence of Transaminase Inhibitors on Viability of Cultured Rat RPE Cells in Glucose-Free Medium
Treatment Viability at 24 h Viability at 72 h
l-CS (1 mM) 74.6 ± 2.1 72.3 ± 6.3
AOAA (1 mM) 70.3 ± 4.6 27.4 ± 3.2*
Glutamine-free medium (plus glucose) 98.3 ± 2.4 95.7 ± 4.9
Glutamine-free medium (minus glucose) 21.4 ± 6.7 16.9 ± 5.3
Table 3.
 
Counteracting the Protective Effect of Monocarboxylates against Transaminase Inhibition
Table 3.
 
Counteracting the Protective Effect of Monocarboxylates against Transaminase Inhibition
Treatment Viability at 72 h (% of Control)
AOAA (1 mM) 27.4 ± 3.2*
AOAA + 5 mM pyruvate 78.3 ± 5.4, †
 + 1 μM 4-CIN 21.4 ± 8.2, ‡
 + Anoxia (72 h) 17.2 ± 1.3, ‡
Table 4.
 
Proliferation of Rat RPE Cells in Serum-Free Culture Medium
Table 4.
 
Proliferation of Rat RPE Cells in Serum-Free Culture Medium
Treatment Incorporation of [3H]thymidine (% of Control)
Control 100 ± 12.9
 + 5 mM glucose 197.4 ± 11.6*
 + 25 mM glucose 205.9 ± 16.6*
 + 5 mM pyruvate 96.9 ± 5.5
 + 5 mM lactate 120.3 ± 16.3
Figure 7.
 
(A) Immunoblot analysis of transporter expression in cultured rat RPE cells (passage 3). Two distinct rat RPE cell lines were analyzed. The first lane represents one culture, and the second lane represents a different culture. The order of loading was the same for each protein analyzed. Arrows: positions of molecular weight markers. A protein with the molecular mass of approximately 45 kDa was detected for MCT1 and two proteins of masses 45 and 55 kDa for GLUT1. The level of actin was approximately equal in each extract. (B) Immunocytochemical localization of MCT1 immunoreactivity in cultured rat RPE cells (passage 3) showing the homogeneous distribution of label.
Figure 7.
 
(A) Immunoblot analysis of transporter expression in cultured rat RPE cells (passage 3). Two distinct rat RPE cell lines were analyzed. The first lane represents one culture, and the second lane represents a different culture. The order of loading was the same for each protein analyzed. Arrows: positions of molecular weight markers. A protein with the molecular mass of approximately 45 kDa was detected for MCT1 and two proteins of masses 45 and 55 kDa for GLUT1. The level of actin was approximately equal in each extract. (B) Immunocytochemical localization of MCT1 immunoreactivity in cultured rat RPE cells (passage 3) showing the homogeneous distribution of label.
Zinn KM, Benjamin-Henkind JV. Anatomy of the human retinal pigment epithelium. Zinn KM Marmor MF eds. The Retinal Pigment Epithelium. 1979;3–31. Harvard University Press Cambridge, MA.
Bok D. The retinal pigment epithelium: a versatile partner in vision. J Cell Sci Suppl. 1993;17:189–195. [PubMed]
Hewitt AT, Adler R. The retinal pigment epithelium and interphotoreceptor matrix: structure and specialized functions. Retina: Basic Science and Inherited Retinal Disease. 1994;1:58–71. Mosby St. Louis.
Eagle RC, Jr. Mechanisms of maculopathy. Ophthalmology. 1984;91:613–625. [CrossRef] [PubMed]
Dorey CK, Wu G, Ebenstein D, Garsd A, Weiter JJ. Cell loss in the aging retina: relationship to lipofuscin accumulation and macular degeneration. Invest Ophthalmol Vis Sci. 1989;30:1691–1699. [PubMed]
Tsacopoulos M, Poitry Yamate CL, MacLeish PR, Poitry S. Trafficking of molecules and metabolic signals in the retina. Prog Retin Eye Res. 1998;17:429–442. [CrossRef] [PubMed]
Winkler BS, Arnold MJ, Brassell MA, Puro DG. Energy metabolism in human retinal Müller cells. Invest Ophthalmol Vis Sci. 2000;41:3183–3190. [PubMed]
Adler AJ, Southwick RE. Distribution of glucose and lactate in the interphotoreceptor matrix. Ophthalmic Res. 1992;24:243–252. [CrossRef] [PubMed]
Poitry S, Poitry Yamate C, Ueberfeld J, MacLeish PR, Tsacopoulos M. Mechanisms of glutamate metabolic signaling in retinal glial (Müller) cells. J Neurosci. 2000;20:1809–1821. [PubMed]
Poitry Yamate CL, Poitry S, Tsacopoulos M. Lactate released by Müller glial cells is metabolized by photoreceptors from mammalian retina. J Neurosci. 1995;15:5179–5191. [PubMed]
Ames A, III, Li YY. Energy requirements of glutamatergic pathways in rabbit retina. J Neurosci. 1992;12:4234–4242. [PubMed]
Winkler BS. Glycolytic and oxidative metabolism in relation to retinal function. J Gen Physiol. 1981;77:667–692. [CrossRef] [PubMed]
Halestrap AP, Price NT. The proton-linked monocarboxylate transporter (MCT) family: structure, function and regulation. Biochem J. 1999;2:281–299.
Pellerin L, Pellegri G, Martin JL, Magistretti PJ. Expression of monocarboxylate transporter mRNAs in mouse brain: support for a distinct role of lactate as an energy substrate for the neonatal vs. adult brain. Proc Natl Acad Sci USA. 1998;95:3990–3995. [CrossRef] [PubMed]
Pellerin L, Pellegri G, Bittar PG, et al. Evidence supporting the existence of an activity-dependent astrocyte-neuron lactate shuttle. Dev Neurosci. 1998;20:291–299. [CrossRef] [PubMed]
Wang L, Tornquist P, Bill A. Glucose metabolism in pig outer retina in light and darkness. Acta Physiol Scand. 1997;160:75–81. [CrossRef] [PubMed]
Halestrap AP, Meredith D. The SLC16 gene family: from monocarboxylate transporters (MCTs) to aromatic amino acid transporters and beyond. Pflüger Arch. .In press
Philp NJ, Yoon H, Lombardi L. Mouse MCT3 gene is expressed preferentially in retinal pigment and choroid plexus epithelia. Am J Physiol. 2001;280:C1319–C1326.
Philp NJ, Yoon H, Grollman EF. Monocarboxylate transporter MCT1 is located in the apical membrane and MCT3 in the basal membrane of rat RPE. Am J Physiol. 1998;274:R1824–R1828. [PubMed]
Bergersen L, Johannsson E, Veruki ML, et al. Cellular and subcellular expression of monocarboxylate transporters in the pigment epithelium and retina of the rat. Neuroscience. 1999;90:319–331. [CrossRef] [PubMed]
Gerhart DZ, Leino RL, Drewes LR. Distribution of monocarboxylate transporters MCT1 and MCT2 in rat retina. Neuroscience. 1999;92:367–375. [CrossRef] [PubMed]
Hamann S, la Cour M, Lui GM, Bundgaard M, Zeuthen T. Transport of protons and lactate in cultured human fetal retinal pigment epithelial cells. Pflugers Arch. 2000;440:84–92. [CrossRef] [PubMed]
Zeuthen T, Hamann S, la Cour M. Cotransport of H+, lactate and H2O by membrane proteins in retinal pigment epithelium of bullfrog. J Physiol. 1996;497:3–17. [CrossRef] [PubMed]
Edwards RB. The isolation and culturing of retinal pigment epithelium of the rat. Vision Res. 1981;21:147–150. [CrossRef] [PubMed]
Weihing RR. In vitro interactions of cytochalasins with contractile proteins. Front Biol. 1978;46:431–444. [PubMed]
Takahashi S, Abe T, Gotoh J, Fukuuchi Y. Substrate-dependence of reduction of MTT: a tetrazolium dye differs in cultured astroglia and neurons. Neurochem Int. 2002;40:441–448. [CrossRef] [PubMed]
LaNoue KF, Berkich DA, Conway M, et al. Role of specific aminotransferases in de novo glutamate synthesis and redox shuttling in the retina. J Neurosci Res. 2001;66:914–922. [CrossRef] [PubMed]
Wood J, Osborne N. Induction of apoptosis in cultured human retinal pigmented epithelial cells: the effect of protein kinase C activation and inhibition. Neurochem Int. 1997;31:261–274. [CrossRef] [PubMed]
Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248–254. [CrossRef] [PubMed]
Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 1983;65:55–63. [CrossRef] [PubMed]
Lobner D. Comparison of the LDH and MTT assays for quantifying cell death: validity for neuronal apoptosis?. J Neurosci Methods. 2000;96:147–152. [CrossRef] [PubMed]
Glocklin VC, Potts AM. The metabolism of retinal pigment cell epithelium. II. Respiration and glycolysis. Invest Ophthalmol Vis Sci. 1965;4:226–234.
Barbehenn EK, Masterson E, Koh SW, Passonneau JV, Chader GJ. An examination of the efficiency of glucose and glutamine as energy sources for cultured chick pigment epithelial cells. J Cell Physiol. 1984;118:262–266. [CrossRef] [PubMed]
Masterson E, Chader GJ. Pigment epithelial cells in culture: metabolic pathways required for phagocytosis. Invest Ophthalmol Vis Sci. 1981;20:1–7.
Irani N, Wirth M, van Den Heuvel J, Wagner R. Improvement of the primary metabolism of cell cultures by introducing a new cytoplasmic pyruvate carboxylase reaction. Biotechnol Bioeng. 1999;66:238–246. [CrossRef] [PubMed]
Gstraunthaler G, Seppi T, Pfaller W. Impact of culture conditions, culture media volumes, and glucose content on metabolic properties of renal epithelial cell cultures: are renal cells in tissue culture hypoxic?. Cell Physiol Biochem. 1999;9:150–172. [CrossRef] [PubMed]
Osborne N, Cazevieille C, Pergande G, Wood J. Induction of apoptosis in cultured human retinal pigmented epithelial cells is counteracted by flupirtine. Invest Ophthalmol Vis Sci. 1997;38:1390–1400. [PubMed]
Osborne N, Nash M, Wood J. Melatonin counteracts apoptosis in cultured human retinal pigment epithelium cells induced by experimental ischaemia. Invest Ophthalmol Vis Sci. 1998;39:2374–2383. [PubMed]
Winkler BS, Sauer MW, Starnes CA. Modulation of the Pasteur effect in retinal cells: implications for understanding compensatory metabolic mechanisms. Exp Eye Res. 2003;76:715–723. [CrossRef] [PubMed]
Winkler BS, Dang L, Malinoski C, Easter SS. An assessment of rat photoreceptor sensitivity to mitochondrial blockade. Invest Ophthalmol Vis Sci. 1997;38:1569–1577. [PubMed]
Winkler BS, Pourcho RG, Starnes C, Slocum J, Slocum N. Metabolic mapping in mammalian retina: a biochemical and 3H-2-deoxyglucose autoradiographic study. Exp Eye Res. 2003;77:327–337. [CrossRef] [PubMed]
Takata K, Hirano H, Kasahara M. Transport of glucose across the blood-tissue barriers. Int Rev Cytol. 1997;172:1–53. [PubMed]
Takata K. Glucose transporters in the transepithelial transport of glucose. J Electron Microsc (Tokyo). 1996;45:275–284. [CrossRef] [PubMed]
Ban Y, Rizzolo LJ. Regulation of glucose transporters during development of the retinal pigment epithelium. Brain Res Dev Brain Res. 2000;121:89–95. [CrossRef] [PubMed]
Watanabe T, Matsushima S, Okazaki M, et al. Localization and ontogeny of GLUT3 expression in the rat retina. Brain Res Dev Brain Res. 1996;94:60–66. [CrossRef] [PubMed]
Zimmerle CT, Tung PP, Alter GM. Ligand-induced asymmetry between active sites of cytoplasmic malate dehydrogenase: a chemical modification study. Biochemistry. 1987;26:8535–8541. [CrossRef] [PubMed]
Miceli MV, Newsome DA, Schriver GW. Glucose uptake, hexose monophosphate shunt activity, and oxygen consumption in cultured human retinal pigment epithelial cells. Invest Ophthalmol Vis Sci. 1990;31:277–283. [PubMed]
Masterson E, Israel P, Chader GJ. Pentose shunt activity in developing chick retina and pigment epithelium: a switch in biochemical expression in cultured pigment epithelial cells. Exp Eye Res. 1978;27:409–416. [CrossRef] [PubMed]
Winkler BS, Arnold MJ, Brassell MA, Sliter DR. Glucose dependence of glycolysis, hexose monophosphate shunt activity, energy status and the polyol pathway in retinas isolated from normal (nondiabetic) rats. Invest Ophthalmol Vis Sci. 1997;38:62–71. [PubMed]
Wood J, Pergande G, Osborne N. Prevention of glutathione-depletion induced apoptosis in cultured human RPE cells by flupirtine. Restor Neurol Neurosci. 1998;12:119–125. [PubMed]
Baird TA, Parsons MW, Barber PA, et al. The influence of diabetes mellitus and hyperglycaemia on stroke incidence and outcome. J Clin Neurosci. 2002;9:618–626. [CrossRef] [PubMed]
Kroemer G, Dallaporta B, Resche Rigon M. The mitochondrial death/life regulator in apoptosis and necrosis. Annu Rev Physiol. 1998;60:619–642. [CrossRef] [PubMed]
Civan MM, Marano CW, Matschinsky FW, Peterson Yantorno K. Prolonged incubation with elevated glucose inhibits the regulatory response to shrinkage of cultured human retinal pigment epithelial cells. J Membr Biol. 1994;139:1–13. [PubMed]
Zhu WH, Loh TT. Effects of Na+/H+ antiport and intracellular pH in the regulation of HL-60 cell apoptosis. Biochim Biophys Acta. 1995;1269:122–128. [CrossRef] [PubMed]
Edwards RB. The use of tissue culture techniques to study normal and diseased retinal pigment epithelium. Osborne NN Chader GJ eds. Progress in Retinal Research. 1983;2:51–66. Pergamon Press Oxford, UK. [CrossRef]
McKenna MC, Hopkins IB, Carey A. Alpha-cyano-4-hydroxycinnamate decreases both glucose and lactate metabolism in neurons and astrocytes: implications for lactate as an energy substrate for neurons. J Neurosci Res. 2001;66:747–754. [CrossRef] [PubMed]
Dimmer KS, Friedrich B, Lang F, Deitmer JW, Broer S. The low-affinity monocarboxylate transporter MCT4 is adapted to the export of lactate in highly glycolytic cells. Biochem J. 2000;350:219–227. [CrossRef] [PubMed]
Philp NJ, Yoon H, Wang D. Polarized expression of monocarboxylate transporters in human retinal pigment epithelium and ARPE-19 cells. Invest Ophthalmol Vis Sci. 2003;44:1716–1721. [CrossRef] [PubMed]
Manning Fox JE, Meredith D, Halestrap AP. Characterisation of human monocarboxylate transporter 4 substantiates its role in lactic acid efflux from skeletal muscle. J Physiol. 2000;529:285–293. [CrossRef] [PubMed]
Figure 1.
 
Rat RPE cells in culture. (A) Cells at passage 3, as commonly used for the experiments outlined. The micrograph shows that cells lost their pigmentation, but retained a homogeneous appearance. (B) Cells labeled with anti-cytokeratin KG 8.13 antibody, which is specific for RPE cells.
Figure 1.
 
Rat RPE cells in culture. (A) Cells at passage 3, as commonly used for the experiments outlined. The micrograph shows that cells lost their pigmentation, but retained a homogeneous appearance. (B) Cells labeled with anti-cytokeratin KG 8.13 antibody, which is specific for RPE cells.
Figure 2.
 
The effect of glucose deprivation on rat RPE cells in culture. (A) Treatment of cells with various media over a 120-hour period, showing the reduction in viability to approximately 70% of the untreated value when glucose was absent. In comparison, there was no significant difference between cells incubated in either 5 or 25 mM glucose. (B) The reduction of viability after 24 hours’ incubation in medium without glucose was not counteracted by 5 mM pyruvate or 5 mM lactate. *P < 0.05 compared with appropriate control cells untreated for the same period (i.e., medium not changed for the experiment although still containing 25 mM glucose by paired Student’s t-test analysis; n = 12).
Figure 2.
 
The effect of glucose deprivation on rat RPE cells in culture. (A) Treatment of cells with various media over a 120-hour period, showing the reduction in viability to approximately 70% of the untreated value when glucose was absent. In comparison, there was no significant difference between cells incubated in either 5 or 25 mM glucose. (B) The reduction of viability after 24 hours’ incubation in medium without glucose was not counteracted by 5 mM pyruvate or 5 mM lactate. *P < 0.05 compared with appropriate control cells untreated for the same period (i.e., medium not changed for the experiment although still containing 25 mM glucose by paired Student’s t-test analysis; n = 12).
Figure 3.
 
The effect of a reintroduction of 25 mM glucose to cells that had been deprived of the sugar for 24 hours. After incubation for 24 hours in standard culture medium without glucose, there was a reduction in cell viability (also shown in Fig. 2 ) to approximately 70% of the untreated cells’ viability (A). However, reintroduction of 25 mM glucose to cells after this 24-hour sugar deprivation promoted the induction of RPE cell death, which was noticeable after a further 48 hours in a glucose-containing medium. Photographs of cells labeled by the TUNEL reaction indicate that cells die by a process characteristic of apoptosis (C; 72 hours after reintroduction of glucose) that is not detected in cells that have not been subjected to prior glucose deprivation (B).
Figure 3.
 
The effect of a reintroduction of 25 mM glucose to cells that had been deprived of the sugar for 24 hours. After incubation for 24 hours in standard culture medium without glucose, there was a reduction in cell viability (also shown in Fig. 2 ) to approximately 70% of the untreated cells’ viability (A). However, reintroduction of 25 mM glucose to cells after this 24-hour sugar deprivation promoted the induction of RPE cell death, which was noticeable after a further 48 hours in a glucose-containing medium. Photographs of cells labeled by the TUNEL reaction indicate that cells die by a process characteristic of apoptosis (C; 72 hours after reintroduction of glucose) that is not detected in cells that have not been subjected to prior glucose deprivation (B).
Figure 4.
 
Dose-dependent effect of the glycolytic inhibitor, iodoacetic acid (IOA), on reduction of rat RPE cell viability after 24 hours, in medium containing glucose. IOA had a similar detrimental effect in such medium whether 5 mM pyruvate, 5 mM lactate, or no monocarboxylates were present. The effect of IOA (5 μM) was slightly but significantly less destructive when pyruvate was present. *P < 0.05 compared with appropriate control cells in medium without IOA, by paired Student’s t-test analysis (n = 9).
Figure 4.
 
Dose-dependent effect of the glycolytic inhibitor, iodoacetic acid (IOA), on reduction of rat RPE cell viability after 24 hours, in medium containing glucose. IOA had a similar detrimental effect in such medium whether 5 mM pyruvate, 5 mM lactate, or no monocarboxylates were present. The effect of IOA (5 μM) was slightly but significantly less destructive when pyruvate was present. *P < 0.05 compared with appropriate control cells in medium without IOA, by paired Student’s t-test analysis (n = 9).
Figure 5.
 
Involvement of the hexose-monophosphate shunt for generation of a small proportion of cell energy in rat RPE cultures. Oxygen deprivation for 24 hours had no significant effect on cell viability, unlike IOA (10 μM) which reduced cells to approximately 25% of control metabolic activity. Although the effect of IOA was reduced slightly by concurrent anoxia, there was no detectable metabolic activity at all in cells incubated in a medium without glucose subjected to anoxia for 24 hours. *P < 0.05, when cells subjected to glucose and oxygen deprivation are compared with cells treated with IOA and anoxia, by paired Student’s t-test analysis (n = 8).
Figure 5.
 
Involvement of the hexose-monophosphate shunt for generation of a small proportion of cell energy in rat RPE cultures. Oxygen deprivation for 24 hours had no significant effect on cell viability, unlike IOA (10 μM) which reduced cells to approximately 25% of control metabolic activity. Although the effect of IOA was reduced slightly by concurrent anoxia, there was no detectable metabolic activity at all in cells incubated in a medium without glucose subjected to anoxia for 24 hours. *P < 0.05, when cells subjected to glucose and oxygen deprivation are compared with cells treated with IOA and anoxia, by paired Student’s t-test analysis (n = 8).
Figure 6.
 
The effect of the pantransaminase inhibitor AOAA on rat RPE cell viability in culture after 72 hours. (A) When AOAA was applied in the presence of glucose, there was no significant effect. There was a dose-dependent reduction in cell viability, however, when AOAA was present in medium without glucose, with the maximum reduction (to approximately 27% of the value of cells in the presence of glucose without AOAA) observed at 1 mM. *P < 0.05, **P < 0.01, compared with appropriate control cells in medium with glucose but without AOAA, by paired Student’s t-test analysis (n = 8). (B) The reduction in viability caused by 1 mM AOAA was significantly counteracted by 5 mM pyruvate or 5 mM lactate. *P < 0.05, compared with cells treated with AOAA alone by paired Student’s t-test analysis (n = 8).
Figure 6.
 
The effect of the pantransaminase inhibitor AOAA on rat RPE cell viability in culture after 72 hours. (A) When AOAA was applied in the presence of glucose, there was no significant effect. There was a dose-dependent reduction in cell viability, however, when AOAA was present in medium without glucose, with the maximum reduction (to approximately 27% of the value of cells in the presence of glucose without AOAA) observed at 1 mM. *P < 0.05, **P < 0.01, compared with appropriate control cells in medium with glucose but without AOAA, by paired Student’s t-test analysis (n = 8). (B) The reduction in viability caused by 1 mM AOAA was significantly counteracted by 5 mM pyruvate or 5 mM lactate. *P < 0.05, compared with cells treated with AOAA alone by paired Student’s t-test analysis (n = 8).
Figure 7.
 
(A) Immunoblot analysis of transporter expression in cultured rat RPE cells (passage 3). Two distinct rat RPE cell lines were analyzed. The first lane represents one culture, and the second lane represents a different culture. The order of loading was the same for each protein analyzed. Arrows: positions of molecular weight markers. A protein with the molecular mass of approximately 45 kDa was detected for MCT1 and two proteins of masses 45 and 55 kDa for GLUT1. The level of actin was approximately equal in each extract. (B) Immunocytochemical localization of MCT1 immunoreactivity in cultured rat RPE cells (passage 3) showing the homogeneous distribution of label.
Figure 7.
 
(A) Immunoblot analysis of transporter expression in cultured rat RPE cells (passage 3). Two distinct rat RPE cell lines were analyzed. The first lane represents one culture, and the second lane represents a different culture. The order of loading was the same for each protein analyzed. Arrows: positions of molecular weight markers. A protein with the molecular mass of approximately 45 kDa was detected for MCT1 and two proteins of masses 45 and 55 kDa for GLUT1. The level of actin was approximately equal in each extract. (B) Immunocytochemical localization of MCT1 immunoreactivity in cultured rat RPE cells (passage 3) showing the homogeneous distribution of label.
Table 1.
 
Effect of Transport Inhibitors on Viability of Cultured Rat RPE Cells
Table 1.
 
Effect of Transport Inhibitors on Viability of Cultured Rat RPE Cells
Treatment (μM) Viability at 24 h Viability at 72 h
CCB (50) 54.1 ± 6.7* 27.1 ± 5.3, **
CCB (1) 93.4 ± 3.2 53.2 ± 6.5*
4-CIN (500) 97.3 ± 3.4 76.1 ± 7.6*
4-CIN (50) 101.3 ± 2.8 98.1 ± 3.2
4-CIN (1) 99.3 ± 4.6 99.2 ± 2.4
Table 2.
 
Influence of Transaminase Inhibitors on Viability of Cultured Rat RPE Cells in Glucose-Free Medium
Table 2.
 
Influence of Transaminase Inhibitors on Viability of Cultured Rat RPE Cells in Glucose-Free Medium
Treatment Viability at 24 h Viability at 72 h
l-CS (1 mM) 74.6 ± 2.1 72.3 ± 6.3
AOAA (1 mM) 70.3 ± 4.6 27.4 ± 3.2*
Glutamine-free medium (plus glucose) 98.3 ± 2.4 95.7 ± 4.9
Glutamine-free medium (minus glucose) 21.4 ± 6.7 16.9 ± 5.3
Table 3.
 
Counteracting the Protective Effect of Monocarboxylates against Transaminase Inhibition
Table 3.
 
Counteracting the Protective Effect of Monocarboxylates against Transaminase Inhibition
Treatment Viability at 72 h (% of Control)
AOAA (1 mM) 27.4 ± 3.2*
AOAA + 5 mM pyruvate 78.3 ± 5.4, †
 + 1 μM 4-CIN 21.4 ± 8.2, ‡
 + Anoxia (72 h) 17.2 ± 1.3, ‡
Table 4.
 
Proliferation of Rat RPE Cells in Serum-Free Culture Medium
Table 4.
 
Proliferation of Rat RPE Cells in Serum-Free Culture Medium
Treatment Incorporation of [3H]thymidine (% of Control)
Control 100 ± 12.9
 + 5 mM glucose 197.4 ± 11.6*
 + 25 mM glucose 205.9 ± 16.6*
 + 5 mM pyruvate 96.9 ± 5.5
 + 5 mM lactate 120.3 ± 16.3
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×